Skip to content

Clinical trials

Completed Lymphoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Status: Completed Country / region: United States Clear all

1,180 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200062
200131
200250
200359
200463
200569
200661
200759
200863
200944
201038
201149
201238
201333
201442
201529
201630
201729
201826
201915
202013
202117
202213
20235
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,180

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)100
M.D. Anderson Cancer Center89
Memorial Sloan Kettering Cancer Center75
Alliance for Clinical Trials in Oncology41
Fred Hutchinson Cancer Center29
Children's Oncology Group24
SWOG Cancer Research Network23
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins22
Case Comprehensive Cancer Center20
Mayo Clinic18

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma1,180
Lymphoma, Non-Hodgkin400
Leukemia388
Lymphoma, Large B-Cell, Diffuse347
Lymphoma, Follicular341
Leukemia, Lymphocytic, Chronic, B-Cell320
Lymphoma, Mantle-Cell299
Hodgkin Disease298
Precursor Cell Lymphoblastic Leukemia-Lymphoma284
Burkitt Lymphoma278

Trials

Showing 1 to 25 of 1,180. Each trial links to its page on Pharma Observatory.

1,080 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.